Nonclinical Development of BCG Replacement Vaccine Candidates

The failure of current Mycobacterium bovis bacille Calmette–Guérin (BCG) vaccines, given to neonates to protect against adult tuberculosis and the risk of using these live vaccines in HIV-infected infants, has emphasized the need for generating new, more efficacious and safer replacement vaccines. W...

Descripción completa

Detalles Bibliográficos
Autores principales: Velmurugan, Kamalakannan, Grode, Leander, Chang, Rosemary, Fitzpatrick, Megan, Laddy, Dominick, Hokey, David, Derrick, Steven, Morris, Sheldon, McCown, David, Kidd, Reginald, Gengenbacher, Martin, Eisele, Bernd, Kaufmann, Stefan H.E., Fulkerson, John, Brennan, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4515585/
https://www.ncbi.nlm.nih.gov/pubmed/26343962
http://dx.doi.org/10.3390/vaccines1020120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4515585/
https://www.ncbi.nlm.nih.gov/pubmed/26343962
http://dx.doi.org/10.3390/vaccines1020120

Ejemplares similares